Humira marketing is a case study in how drug makers promote expensive, dangerous and often unnecessary prescription drugs risking public safety and at taxpayer expense.
Before creating AbbVie, Abbott had already lobbied Congress successfully to get Humira covered by Medicare and seeded seniors with "free samples" to create "demand." Today Humira costs $2,984 per one syringe, pricing which the U.S. Congress is investigating. The cost of the Medicare-reimbursed Humira has been raised 27 times since the drug's launch.
continue reading here click here